NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/15/2025
Back to search
Official data from USPTO
PROTEAN MAPS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PROTEAN MAPS
ST13
US500000097515272Class
42, 44
Filing
97515272
Registration
7757271
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
04/16/2025
Trademark type
Word
Nice classes
42, 44
Filing date
07/22/2022
Registration date
04/15/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/15/2025
Last transaction
04/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2018-07-00
First use in commerce
2018-12-00
Drawing code
4
Owner type
03
Owner location
Orlando, FL
Examiner
AYALA, LOURDES
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Protean BioDiagnostics Inc.
Representatives
Allison R. Imber ALLEN, DYER, DOPPELT & GILCHRIST, P.A.
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical laboratory services; Medical research services; Scientific laboratory services; Biomedical research services; Chemical research services; Pharmaceutical research services; Genetic testing for scientific research purposes; DNA analysis services for scientific research purposes; Medical and scientific research in the field of immunohistochemistryin-situ hybridizationmolecular diagnosticsgeneticspathology; Medical and scientific research servicesidentifying genetic characteristics that affect patients' likelihood or inherited risk of developing cancer and their responsiveness or resistance to cancer treatments and therapiesthe reasons for such likelihoodinherited risk or resistance; Medical and scientific research servicesidentifying genetic characteristics to predict the prognosisclinical courselikelihood of recurrence of patients' cancersillnesses or malignancies and the effectiveness of treatments and therapies therefor; none of the foregoing services including monitoring the variables or changes in genomesDNAgenes
Class 44
Genetic testing for medical purposes; DNA screening for medical purposes; Medical diagnostic testingmonitoring and reporting services; Medical services; Medical analysis services for the diagnosis and treatment of cancer; Medical servicespathology services for the diagnosis and treatment of disease; none of the foregoing services including monitoring the variables or changes in genomesDNAgenes
Publications
History of USPTO decisions and trademark events.
33 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/15/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/25/2025
PUBO
PUBLISHED FOR OPPOSITION
02/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/30/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/29/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/29/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/29/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/29/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/29/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/29/2024
GNRT
NON-FINAL ACTION E-MAILED
07/29/2024
CNRT
NON-FINAL ACTION WRITTEN
07/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/13/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/13/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03/12/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03/12/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/14/2023
GNFR
FINAL REFUSAL E-MAILED
12/14/2023
CNFR
FINAL REFUSAL WRITTEN
12/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/16/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/15/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/15/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
08/08/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
08/08/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/16/2023
GNRT
NON-FINAL ACTION E-MAILED
05/16/2023
CNRT
NON-FINAL ACTION WRITTEN
05/16/2023
DOCK
ASSIGNED TO EXAMINER
05/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/14/2022
NWAP
NEW APPLICATION ENTERED
07/27/2022
Continuous trademark protection
Get notified about every new filing that threatens PROTEAN MAPS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.